Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently found in human glioblastomas 1 and cytogenetically normal acute myeloid leukaemias (AML) 2 . These alterations are gain-of-function mutations in that they drive the synthesis of the 'oncometabolite' R-2-hydroxyglutarate (2HG) 3 . It remains unclear how IDH1 and IDH2 mutations modify myeloid cell development and promote leukaemogenesis. Here we report the characterization of conditional knock-in (KI) mice in which the most common IDH1 mutation, IDH1(R132H), is inserted into the endogenous murine Idh1 locus and is expressed in all haematopoietic cells (Vav-KI mice) or specifically in cells of the myeloid lineage (LysM-KI mice). These mutants show increased numbers of early haematopoietic progenitors and develop splenomegaly and anaemia with extramedullary haematopoiesis, suggesting a dysfunctional bone marrow niche. Furthermore, LysM-KI cells have hypermethylated histones and changes to DNA methylation similar to those observed in human IDH1-or IDH2-mutant AML. To our knowledge, our study is the first to describe the generation and characterization of conditional IDH1(R132H)-KI mice, and also the first report to demonstrate the induction of a leukaemic DNA methylation signature in a mouse model. Our report thus sheds light on the mechanistic links between IDH1 mutation and human AML.
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IDH1/IDH2 mutations typically produce mutant enzymes with aberrant activity. Whereas wild-type (WT) Idh proteins metabolize isocitrate and NADP 1 to yield a-ketoglutarate (aKG) and NADPH, mutant Idh proteins convert aKG into 2HG while consuming NADPH 3 . 2HG competitively inhibits tet methylcytosine dioxygenases (Tet2), which regulate DNA methylation, as well as JmjC domaincontaining histone demethylases [4] [5] [6] . Accordingly, human AML cells with IDH1/IDH2 mutation show global DNA hypermethylation 5 .
To create a murine model of the IDH1(R132H) mutation, we used the lox-stop-lox (LSL) system to generate a conditional Idh1 knock-in (KI) mouse (Idh1 , LsyM-KI), because the LysM promoter is activated very early during myeloid development 8 and human AML leukaemic stem cells show similarities with very early myeloid primed progenitors (LMPP) 9 . LysM-KI mice were born at the expected Mendelian ratio, were viable and fertile, and had normal lifespans. However, serum 2HG levels were elevated approximately tenfold in both young (7-16 weeks old) and older (47-56 weeks old) LysM-KI mice ( Supplementary Fig.  3a-c) . Whereas peripheral blood cell counts of young LysM-KI mice were normal, older (42-46 weeks old) mutants developed anaemia ( Supplementary Fig. 3d, e) . In the OP9/OP9-DL1 in vitro differentiation system 10 , haematopoietic cell lineages developed normally from several IDH1(R132H)-KI embryonic stem cell clones ( Supplementary  Fig. 4 ). Macroscopic analysis of mice revealed mild splenic enlargement in young LysM-KI mice that progressed to overt splenomegaly in all older mutants. Histologically, splenic architecture became increasingly disorganized, with age-dependent expansion of spaces between lymphoid follicles and obvious extramedullary haematopoiesis (Fig. 1a, b) .
We next evaluated the haematopoietic stem cell (HSC) and haematopoietic progenitor cell (HPC) compartments in LysM-KI mice. Bone marrow (BM) cellularity was normal in young LysM-KI mice but reduced in older mutants (Fig. 1c) , where it correlated inversely with splenomegaly and the degree of anaemia. Histologically, the BM of young mutants appeared normal but the BM of older mutants showed fewer mature cells and more immature cells (Fig. 1d) . Flow cytometric analyses of BM and spleen revealed altered numbers of mature cells (CD11b (Fig. 1e, f) . More refined flow cytometric analyses confirmed that lineagenegative (Lin 2 ) cells underwent an age-dependent expansion in LysM-KI BM (Fig. 2a, b Table 1 ). In colony-forming cell (CFC) assays, BM cells from young or older LysM-KI mice showed statistically normal production of granulocyte (G), granulocyte-macrophage (GM), granulocyte-erythrocyte-macrophage-megakaryocyte (GEMM), and macrophage (M) colonies (Fig. 2c) . Flow cytometric analysis of nucleated splenic cells from older LysM-KI mice revealed significantly elevated numbers of LSK and LRP cells, recapitulating the pattern observed in the bone marrow of these mice (Fig. 2a, d ). CFC assays of nucleated splenic cells showed increased numbers of all four myeloid colony types in LysM-KI mice (Fig. 2e) . These data confirm that extramedullary haematopoiesis occurs in older LysM-KI mice.
We speculated that the LRP accumulation in LysM-KI BM (and spleen), despite the near-normal peripheral blood counts of these animals and their normal BM cell CFC activity, might be due to increased symmetric cell division and proliferation, and/or a partial block in differentiation. Serial plating experiments showed that, whereas control BM cells stopped proliferating after three rounds of plating (24 days), LysM-KI BM cells continued to grow at an exponential rate for six rounds of plating (45 days) (Fig. 2f) .
To extend our findings, we crossed Idh1 LSL/WT mice with VavCre mice 11 to generate Vav-KI mutants expressing IDH1(R132H) in all haematopoietic cells, from LT-HSCs to terminally differentiated cells. Lin-negative, LSK, LRP and CLP cells were all significantly increased in BM of young Vav-KI mice ( Supplementary Fig. 5a ), as were splenic LSK, LK, LRP, MEP and CLP cells (Supplementary Fig. 5b ). Like young LysM-KI mice, young Vav-KI mice had normal total BM cell numbers and showed no overt haematological changes ( Supplementary Fig. 5c-e) .
Next, we performed competitive BM repopulation assays in which equal numbers (10 5 ) of nucleated BM cells from donor mice (control or LysM-KI; CD45. ). LysM-KI BM cells showed no defects in short-term or long-term repopulation capacity for at least 170 days after transplantation, and relative peripheral blood cell counts were not altered in recipients of LysM-KI BM ( Supplementary Fig. 6a, b) .
The homeostasis of HSCs and HPCs is influenced by reactive oxygen species (ROS) 12, 13 . Because high ROS reduces HSC longevity, these cells strive to keep ROS low 13 . In contrast, higher levels of ROS in developing myeloid cells may be necessary for their differentiation 13 . ROS elevation in AML cells triggers their differentiation 14 . It has been assumed that IDH1/IDH2 mutations increase ROS 3 . However, when using CM-H 2 DCFDA (5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate, acetyl ester; a membrane-permeable indicator of reactive oxygen species) to measure total ROS in granulocytes (CD11b Fig. 7c -e). Taken together, these data indicate that the phenotype of LysM-KI mice is not due to alterations in ROS or NADPH levels, nor to 2HG-mediated complete abolition of myeloid differentiation.
The hypoxia-inducible transcription factors Hif1a and Hif2a are critical for HSC survival and maintenance 15 but their involvement in HPC differentiation and beyond is unclear. IDH1 mutations have been shown to alter Hif1a stability 6, 16 . We compared messenger RNA levels of several Hif1a target genes in sorted control and LysM-KI LSK cells but observed no differences ( Supplementary Fig. 8 ). Thus, it is unlikely that Hif1a signalling is altered in LysM-KI LSK cells.
To analyse global mRNA expression, we performed gene expression microarray analyses of sorted LSK cells from young LysM-KI and control mice. Two-way hierarchical clustering of significantly altered genes (P value , 0.05, .1.5-fold change) revealed a clear separation of control and LysM-KI samples ( Supplementary Fig. 9 ). Gene ontology analysis of the identified gene signature (Supplementary Table 3 ) revealed a significant enrichment of genes in several categories related to cellular growth and proliferation (Supplementary Table 4) .
Human gliomas 17 and AMLs with IDH1/IDH2 mutations have DNA hypermethylation that, in AML, is caused by 2HG-mediated inhibition of Tet2 (ref. 5). 2HG also inhibits histone demethylases, resulting in hypermethylation of histone lysine residues (especially in H3) 4, 6 . To examine DNA methylation, we performed high-throughput 
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sequencing of bisulphite-treated DNA from sorted LSK cells from young LysM-KI and control mice. DNA from LysM-KI LSK cells showed a significantly greater proportion of highly methylated CpG sites, with a marked increase in CpG sites showing greater than 80% methylation (Fig. 3a) . A more detailed analysis of the differential distribution pattern of DNA methylation revealed wide-spread global changes, with all chromosomes equally affected ( Supplementary  Fig. 10a , b and Supplementary Table 5) . A clear preference for promoters and intragenic regions was observed that paralleled the changes in DNA methylation observed in human IDH1/IDH2-mutant AMLs (Fig. 3b, Supplementary Fig. 10a , b and Supplementary Table 6 ). Ingenuity pathway analysis (IPA) implicated several signalling pathways involved in haematopoietic cell proliferation and differentiation, leukaemogenesis and leukaemic stem cell maintenance (Supplementary Table 7 and Supplementary Fig. 11 ) [19] [20] [21] [22] including the WNT, NOTCH and TGF-b pathways, which are also targeted by aberrant methylation in human IDH1/IDH2-mutant AMLs 18 .
Immunoblotting of lysates from control and LysM-KI BMDMs revealed increased methylation of multiple H3 lysine residues (Fig. 3c) .
In conclusion, we show that the IDH1(R132H) mutation in all haematopoietic cells (Vav-KI), and in the myeloid lineage in particular (LysM-KI), results in the accumulation of LSK and LRP cells first in the bone marrow and later in the spleen. We believe that the accumulations of these cells are most likely due to 2HG-induced DNA and histone hypermethylation that affect LSK cell division and/or differentiation ( Supplementary Fig. 1 
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not completely block myeloid differentiation may explain why IDH1/ IDH2 mutations are found in almost all FAB (French-AmericanBritish classification) AML subtypes 23 . Moreover, our mutants show extramedullary haematopoiesis, suggesting a dysfunctional bone marrow niche. Extramedullaryhaematopoiesisoccursinmyelodysplastic syndromes, which frequently progress to AML and harbour IDH1/ IDH2 mutations in 10-15% of cases 24 . Our study is, to our knowledge, the first to model epigenetic changes of human IDH1/IDH2-mutant AML in mice and thereby advances and will advance our understanding of the links between IDH1/IDH2 mutations and leukaemogenesis.
METHODS SUMMARY
Methods used for the generation of the conditional IDH1(R132H) KI mouse, for the generation of KI embryonic stem cell clones expressing IDH1(R132H), the OP9 in vitro differentiation system, for histology, flow cytometric analyses, cell sorting, CFC assays, competitive BM repopulation assays, generation of BMDMs, mRNA extraction, cDNA synthesis, real-time RT-PCR analysis, immunoblotting, mass spectrometry, DNA methylation analysis, and mRNA expression profiling are detailed in the Methods.
For all experiments, LysM-KI mice were heterozygous for both 
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Generation of LSL-Idh1R132H mice and breeding. The targeting vector containing both the loxP-flanked STOP (LSL) cassette and the IDH1(R132H) mutation is shown in Supplementary Fig. 2 . The LSL cassette (Addgene) is composed of the puromycin resistance gene, a splicing acceptor sequence that stops transcription at the insertion point, and four repeats of the SV40 polyA sequence. Thus, the presence of LSL inhibits expression of the IDH1(R132H) protein, and Idh1 LSL/WT mice are therefore heterozygous for the Idh1 wild-type allele. Cre-mediated excision of LSL allows expression of the IDH1(R132H) protein (Idh1 LSL/WT Cre 1 ). The targeting vector was assembled by cloning the LSL cassette plus PCRgenerated genomic fragments of the Idh1 gene representing short, middle and long arms of homology into the DT-A vector where the middle fragment contains murine Idh1 exon 4 bearing the R132H mutation, which was created by PCRbased mutagenesis. The linearized targeting vector was electroporated into E14K or Bruce4 embryonic stem cells. Homologous recombination was confirmed by Southern blotting using 59-flanking, 39-flanking, and puromycin-specific probes. Chimaeric mice were produced by microinjection of targeted embryonic stem cells into E3.5 blastocysts. Chimaeras derived from E14K or Bruce4 embryonic stem cells were bred to C57BL/6J or B6-Tyrc-2J/J mice, respectively. Germline transmission of the mutant Idh1 allele was confirmed by genomic Southern blotting. Both E14K-derived and Bruce4-derived strains were crossed to C57Bl/6J, and F2-F5 generations were used for analysis. The phenotypes of the resulting progeny were identical. For transplantation studies only offspring derived from the Bruce4-derived chimaeras was used. Pups were genotyped by PCR analysis using specific primer pairs to detect the wild-type and mutant Idh1 alleles. Sense and antisense primers for the KI, wild-type and LSL alleles were 59-ACCAGCACCTCCC AACTTGTAT-39, 59-AGGTTAGCTCTTGCCGATCCGT-39, and 59-CAGCA GCCTCTGTTCCACATAC-39, which yielded PCR products of the predicted sizes of 394 base pairs (bp), 307 bp, and 223 bp, respectively (Supplementary Fig. 2c ). All animals were treated in accordance with the NIH Guide for Care and Use of Laboratory Animals as approved by the Ontario Cancer Institute Animal Care Committee (Toronto, Ontario, Canada).
LysMCre mice (B6.129P2-Lyz2tm1(cre)Ifo/J; catalogue no. 004781), VavCre mice (B6.Cg-Tg(Vav1-cre)A2Kio/J; catalogue no. 008610) and CD45.1 mice (B6.SJL-Ptprca Pepcb/BoyJ; catalogue no. 002014) were purchased from the Jackson Laboratory. LysMCre mice and VavCre mice were backcrossed into the C57Bl/6J background for at least 10 generations. LysM-KI mice were generated by breeding Idh1
LSL ). All animal procedures were approved by the Animal Care and Use Committee of the University Health Network (Toronto, Ontario, Canada). Generation of IDH1(R132H)-KI embryonic stem cell clones. KI embryonic stem cells which had been generated while making the KI mouse were expanded and transiently transfected with pCAGGS-nlsCre using Lipofectamine2000 (Invitrogen). After transfection, cells were trypsinized and plated on gelatincoated cell culture plates. Single colonies were picked and plated in duplicates into 96-well plates to test for puromycin sensitivity as the Cre-mediated recombination of the LSL cassette results in loss of the puromycin-resistance cassette. Puromycinsensitive clones were expanded, tested by PCR-genotyping, and then used for in vitro differentiation experiments. OP9/OP9-DL1 embryonic stem cell in vitro differentiation system. Experiments including co-culture and differentiation of embryonic stem cells in the presence of OP9 or OP9-DL1 cells were carried out as described elsewhere 9 . Histology. For histological analyses, mouse tissues were fixed in 10% buffered formalin. After fixation, femurs were decalcified in formic acid. Fixed tissues were paraffin-embedded, sectioned, and stained with haematoxylin and eosin according to standard laboratory protocols. Flow cytometric analyses. Flow cytometric analyses were performed according to standard protocols. In brief, mice were euthanized, single-cell suspensions from bone marrow (BM) were generated by flushing out the bone marrow from tibia and femur in Iscove's modified Dulbecco's medium supplemented with 2% heat-inactivated fetal bovine serum (HI-FBS) (IMDM2). Single-cell suspensions of spleens were generated by mashing the spleen in IMDM2. Cell suspensions were passed through 70 mm cell strainers, centrifuged and resuspended in ammonium-based red cell lysis buffer (Sigma ), 2% HI-FBS, 5 mM EDTA, pH 8.0). Viable cell numbers were determined by cell counting after trypan blue staining.
For flow cytometric analyses, cells were incubated in Fc block (BD Biosciences) and then immunostained with fluorophore-linked antibodies (BD Biosciences, eBioscience). For immunostaining of lineage-positive cells, a cocktail containing biotin-labelled primary antibodies against CD5, B220, CD11b, 7-4, Gr-1 and Ter-119 (Miltenyi Biotec) was used, followed by staining with streptavidin-linked fluorophore-labelled secondary antibodies.
To detect total reactive oxygen species (ROS), immunostained cells were incubated with the live cell dye CM-H 2 DCFDA (100 mM) at 37 uC for 15 min followed by two washes in flow cytometric buffer. flow cytometric data were acquired on a BD CantoII and analysed using FlowJo (TreeStar). For flow cytometric analyses of differentiated cells, 10 4 -10 5 events were acquired. For HSC and HPC analyses, up to 2.5 3 10 6 events were acquired. Statistical analyses of flow cytometric data were performed using the GraphPad Prism software. LSK cell sorting. Single-cell suspensions from BM were generated as described above from young mice (8 to 12 weeks of age) and cells were resuspended in flow cytometric buffer and counted. Lineage-negative cells were isolated using the Miltenyi lineage cell depletion kit. Cells were counted and immunostained as described above with anti-lineage-biotin/streptavidin-APC-Cy7, anti-cKit-PECy7 and anti-Sca-1-APC antibodies. Cells were then sorted on a BD FACSAria cell sorter, collected in IMDM2, centrifuged and pellets shock-frozen on dry ice and stored at 280 uC until further processing. Real-time RT-PCR analysis. RNA was purified from sorted LSK cells using TRIzol (Invitrogen), resuspended in water and quantified on a NanoDrop spectrophotometer before transcription into cDNA using the iScript complementary DNA synthesis kit (Bio-Rad). Primers used for RT-PCR are listed in Supplementary Table 2 . Real-time RT-PCR analyses were performed using Power SybrGreen on a 7900HT Fast-Real Time PCR system (Applied Biosystems). C t values were normalized to the housekeeping gene Hprt (DC t ) and then to the average of the D C t values of all samples (DDC t ). Relative mRNA expression levels were calculated (2 {DDCt ) and normalized to the average of the relative control mRNA expression levels. Colony-forming cell (CFC) assays. Single-cell suspensions from BM or spleen from control and LysM-KI mice were generated as described above. Cells were then plated at a density of 10 4 ml 21 for BM and 10 5 ml 21 for spleen in triplicates in complete methylcellulose media containing stem cell factor, Il-3, Il-6 and erythropoietin (Stem Cell Technologies, M3434). Colonies were counted after 7 days at 37 uC and 5% CO 2 . For serial plating cells were collected from methylcellulose media, washed once in IMDM2, counted and replated in complete methylcellulose media at a density of 10 4 ml
21
. Bone marrow competitive repopulation experiments. For competitive BM transfer, donor BM cells from control or LysM-KI mice (CD45. 2 1 ), and competitor BM cells from WT mice (CD45.1 1 ), were isolated as described above and then washed in PBS 2/2 twice. Cell numbers were adjusted to 10 6 ml
. Lethallyirradiated (10.5 Gy) recipient mice (CD45.1 1 ) were injected with 10 5 donor BM cells plus 10 5 competitor BM cells (2 3 10 5 total). For flow cytometric analyses of peripheral blood, mice were bled from the tail vein and immunostaining was carried out as described above. Immunostained blood samples were fixed in FoxP3 fixation buffer (eBioscience) to lyse red blood cells, washed in flow cytometric buffer, and analysed by flow cytometry. Generation of bone marrow-derived macrophages (BMDMs). BMDMs were generated from single-cell BM suspensions of young control or LysM-KI mice using a standard in vitro M-CSF-based differentiation protocol. In brief, 5 3 10 6 cells were plated on a 10-cm tissue culture plate in 5 ml of RPMI1640 media supplemented with 10% HI-FBS and 50 ng ml 21 M-CSF. On days 2, 3, and 4 an additional 1 ml of the complete media was added to every tissue culture plate. Cells were collected on day 5 of the in vitro differentiation procedure and washed in PBS containing Mg 21 and Ca 21 (PBS
1/1
) before being used in experiments. Immunoblot analysis. For immunoblot analysis of histone-3 methylation, equal numbers of BMDMs were generated as described above and lysed in 13 cell lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, 1% Triton X-100) supplemented with EDTA-free protease inhibitor cocktail (Roche). SDS (1%) was added to lysates and incubation was continued for another 30 min. Lysates were centrifuged, loading buffer was added to supernatants, and samples were subjected to electrophoresis on 12% Bis-Tris gels using MES running buffer (Invitrogen). Separated proteins were transferred onto nitrocellulose membranes (Invitrogen). Proteins were then detected using standard laboratory procedures. Primary antibodies used in this study recognized total histone-3 (Abcam ab10799), histone-3 K4me3 (Millipore 07-473), histone-3 K9me3 (Abcam ab8898), histone-3 K27me3 (Millipore 07-449), histone-3 RESEARCH LETTER
